Chronic infections and atherosclerosis had uncertain associations for years (
22).
H. pylori was approved as a possible risk factor for ischemic vascular disease in 1998, (
3), and
C. pneumoniae was known as a suspicious agent in atherosclerosis process (
4,
23). In a study executed in the United States during 1996, Cytomegaloviruses preventive therapy with ganciclovir showed effectiveness in prevention of restenosis and atherosclerosis in transplanted organs (
24). In a few studies, presence of Cytomegaloviruses IE (immediate early) antigen and Cytomegaloviruses DNA in the vessel wall was associated with the pathological process of atherosclerosis formation (
25).
Furthermore, Cytomegaloviruses positivity was introduced as a result of atherosclerosis plaque formation; because active Cytomegaloviruses infection was present in a greater proportion of CAD patients rather than healthy controls indicating that CAD patients are more susceptible of Cytomegaloviruses (
26). The most ideal study is the measurement of Cytomegaloviruses DNA and serology criteria before and after acute myocardial infarction with regular intervals, yet as it cannot predict the acute myocardial infarction incidence, this study can strongly confirm the need for further evaluations with periodic laboratory studies of CVD patients until their probable acute myocardial infarction incidence is determined. Our study was designed to determine whether chronic infections make a poor prognosis for atherosclerosis plaques or immunological changes after acute myocardial infarction due to atherosclerosis plaques make a good environment for common bacterial and viral agents.
Investigation of H. pylori, C. pneumoniae and Cytomegaloviruses in coronary artery specimens of cadavers with atherosclerotic plaque, ding in 24 hours with and without acute myocardial infarction, could answer this question to some extent. Our study on cadavers has shown significant Cytomegaloviruses positivity in cadavers expiring due to acute myocardial infarction (P < 0.01) while H. pylori and C. pneumoniae positivity were not detected. Although cadavers do not have immunological blood changes (the absence of increased cytokines serum concentration), yet in our study cadavers showed higher rates of Cytomegaloviruses positivity in coronary arteries with atherosclerotic plaques. These results suggest that Cytomegaloviruses infection can affect atherosclerosis prognosis proposing that chronic infections such as Cytomegaloviruses can worsen atherosclerotic plaques resulting in CAD.
Yi et al. investigated the presence of Cytomegaloviruses and its antigens in internal carotid arteries of patients with cerebral vascular attacks in a Chinese population during 2008, showing the significantly higher presence of Cytomegaloviruses DNA, in the case group compared to those without cerebral vascular attacks (
25). During 2009 Xenaki et al. reported no significant difference between specimens of coronary arteries with atherosclerotic plaques and specimens of normal vessels regarding Cytomegaloviruses positivity (
27). However, the atherosclerotic and normal samples were extracted from the same subjects. On the other hand, Xenaki’s study confirmed that Cytomegaloviruses infection may not result in atherosclerosis and that atherosclerotic plaque formation did not increase the incidence of Cytomegaloviruses infection; the latter was similar to that found in the present study. Additionally this study did not confirm the presence of
C. pneumoniae and
H. pylori in neither acute myocardial infarction nor non- acute myocardial infarction group.
This could suggest that there is no association between these two bacteria and progression of atherosclerotic plaque mortality due to acute myocardial infarction, while in a study by same authors in 2009 (
28),
C. pneumoniae was detected in high proportions in atherosclerotic plaques compared to the control group supporting the role of
C. pneumoniae in atherosclerotic plaque formation. Ozdogru et al. (
16) published a study on
H. pylori -IgG in three groups of angiographic proven CAD patients including 163 myocardial infarctions, 106 unstable anginas and 84 stable anginas, compared to 163 controls with normal coronary arteries. Ozdogru proposed similar seropositivity rates for
H. pylori in the control and patient groups and the results were approved in the present study stating no differences were detected in
H. pylori DNA between the two groups of cadavers. However this study is limited to dead cases, the result may be different in alive cases.
One potential criticism may arise over this study and that is the significant age difference between our groups. About Cytomegaloviruses epidemiology in a study from Finland, the seroprevalence rates were 47% in 10 to 12 year-olds, 68% in 15 to 35 year-olds and 81% among 36 to 60 year-olds (
29). According to this age distribution, we did not have any significant difference among age categories mentioned above in our two groups (
Table 2). In a US population based study, Cytomegaloviruses seroprevalence increased from 36% in 6 to 11 year-olds to 91% in those aged > 80 years (
30). We had one cadaver from the acute myocardial infarction group, older than 80 years old, with negative Cytomegaloviruses PCR test result (
H. pylori and
C. pneumoniae were also negative). In the mentioned US study, other factors associated with Cytomegaloviruses seropositivity were female sex, foreign birthplace, low household income, household crowding, and low household education (
31); but in this study, the gender difference between acute myocardial infarction and non- acute myocardial infarction group was not significant. Dowd et al. in 2009 reported that socioeconomic inequality affected early and middle age seroprevalence of Cytomegaloviruses infection in a US population. It is substantial to evaluate these variables in future similar studies on cadavers.
It was conclude that Cytomegaloviruses chronic infection may have a definite role in prognosis of atherosclerotic plaques but it does not have any effects in atherosclerotic plaques formation, so attempts for eradication of Cytomegaloviruses in CAD proven patients may decrease the prevalence of acute myocardial infarction and improve their prognosis.